No Data
No Data
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
Map Medical (301033.SZ) granted 0.461 million restricted stocks at a grant price of 22.8 yuan/share.
Map Medical (301033.SZ) announced that the company's board of directors believes that the 'Guangzhou Map Regenerative Medical Technology Co., Ltd. Equity Transfer Agreement' signed by the company and Guangzhou Wanglaoji Zhongyi Pharmaceutical Co., Ltd. and other parties meets the conditions for related transaction and the relevant laws and regulations, and agreed to sign the agreement. The announcement stated that the transaction will not affect the company's normal production and operation, and will be conducive to improving the company's profitability and enhancing its rapid development in the medical field.
Meipu Medical (301033.SZ) granted 94,000 restricted stocks to 3 incentive objects.
Meipu Medical (301033.SZ) announced that the board of directors of the company believes that the Guangzhou Meipu Regenerative Medical Technology Co., Ltd.'s equity transfer plan to Xu Wei is in line with the company's long-term development strategy.
Meipu Medical (301033.SZ) is planning to distribute 4 yuan for every 10 shares on June 26th after ex-right and ex-dividend.
Map Medical (301033.SZ) announced that the company's annual equity distribution plan for 2023: cash dividend of 10 shares...
The general manager of Maipu Medical (301033.SZ) completed an increase of 7,600 shares
Maipu Medical (301033.SZ) issued an announcement. As of the disclosure date of this announcement, Wang Jianhua, the company's director and general manager, has...
Maipu Medical (301033.SZ) was granted a cumulative increase of 5,200 shares by Director and General Manager Wang Jianhua
Zhitong Finance App News, Maipu Medical (301033.SZ) announced that Wang Jianhua, the company's director and general manager, has already passed halfway through the plan to increase his holdings. Wang Jianhua has increased his holdings by 5,200 shares, accounting for 0.0079% of the company's total share capital. The increase amount is 152,800 yuan (not including transaction fees).
No Data